Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging?

Tadashi Hara,Tatsuya Higashi,Yuji Nakamoto,Tsuyoshi Suga,Tsuneo Saga,Takayoshi Ishimori,Koichi Ishizu,Hidekazu Kawashima,Shigeto Kawase,Keiichi Matsumoto,Kaori Togashi

Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging?

2009

Tadashi Hara
Tatsuya Higashi
Yuji Nakamoto
Tsuyoshi Suga
Tsuneo Saga
Takayoshi Ishimori
Koichi Ishizu
Hidekazu Kawashima
Shigeto Kawase
Keiichi Matsumoto
Kaori Togashi

Objectives The purpose of this study was to evaluate the adverse effects of chronic marked hyperglycemia on clinical diagnostic performance of positron emission tomography (PET) using 18F-fuorodeoxyglucose (FDG).

Keywords:

Radiology
Hepatocellular carcinoma
Positron emission tomography
Medicine
Pathology
Adverse effect
Nuclear medicine
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations